Secondary Lung Cancer among Survivors of Adolescent and Young Adult Cancer: A Population-Based Study
- 24 June 2025
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 34 (9) , 1618-1626
Abstract
Background: Survivors of adolescent and young adult (AYA, ages 15–39 years at diagnosis) cancer are at increased risk for subsequent malignant neoplasms (SMN), of which lung cancer is the most lethal. Factors contributing to lung SMN development and outcomes are not well characterized. Methods: Survivors of AYA cancer diagnosed between 1998 and 2020 were identified in the California Cancer Registry (n = 251,632). Pearson’s χ2 and Fisher’s exact tests were used to determine associations between sociodemographic and cancer characteristics and SMN status. Multivariable Cox proportional hazard regression, adjusting for age, time from primary diagnosis, race/ethnicity, insurance, primary cancer site, stage, and treatment, evaluated associations between these characteristics and the incidence and mortality of lung cancer as first SMN. Results: A total of 675 (0.7%) survivors were diagnosed with lung SMN, of whom 487 (72.1%) died. The median time from primary diagnosis to lung SMN was 13.0 years (IQR 4.0–20.0 years). Nearly half (46.5%) of survivors with lung SMN had metastatic disease. Non-Hispanic Black survivors were more likely than non-Hispanic White survivors to develop lung SMN [adjusted HR (aHR) = 1.47; 95% confidence interval (95% CI), 1.13–1.91] but were not more likely to die from lung SMN (aHR = 0.84; 95% CI, 0.56–1.27). Primary cancer treatment with both chemotherapy and radiation was associated with a greater likelihood of lung SMN (aHR = 1.41; 95% CI, 1.11–1.80) compared with receiving neither. Conclusions: Lung SMN has a long latency and high mortality among survivors of AYA cancer. Impact: More research is needed on lung cancer prevention, education, and early detection, particularly among survivors at higher risk.Keywords
All Related Versions
Funding Information
- National Cancer Institute (P30CA014089)
This publication has 41 references indexed in Scilit:
- Long-term second primary cancer risk in adolescent and young adult (15-39 years) cancer survivors: a population-based study in the Netherlands between 1989 and 2018ESMO Open, 2024
- Annual report to the nation on the status of cancer, part 1: National cancer statisticsCancer, 2022
- Screening for Lung CancerJAMA, 2021
- Long‐term survival among 5‐year survivors of adolescent and young adult cancerCancer, 2020
- Cause‐specific mortality in survivors of adolescent and young adult cancerCancer, 2020
- Incidence, Risk Factors, and Mortality Associated With Second Malignant Neoplasms Among Survivors of Adolescent and Young Adult CancerJAMA Network Open, 2019
- Impact of Whole Lung Irradiation on Survival Outcome in Patients With Lung Relapsed Ewing SarcomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2018
- Conditional relative survival among long‐term survivors of adolescent and young adult cancersCancer, 2018
- Increased risk of second malignant neoplasms in adolescents and young adults with cancerCancer, 2015
- The influence of Hispanic ethnicity on nonsmall cell lung cancer histology and patient survivalCancer, 2012